{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:35:21Z","timestamp":1792157721170,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"USC Norris Comprehensive Cancer Center","award":["P30 CA014089"],"award-info":[{"award-number":["P30 CA014089"]}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.clgc.2016.01.013","type":"journal-article","created":{"date-parts":[[2016,2,6]],"date-time":"2016-02-06T20:01:03Z","timestamp":1454788863000},"page":"450-456.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer"],"prefix":"10.1016","volume":"14","author":[{"given":"Tanya B.","family":"Dorff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne K.","family":"Schuckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Rashad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajaz","family":"Bulbul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Pinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Danenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eila","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2016.01.013_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.urolonc.2006.08.029","article-title":"Incidence trends in primary malignant penile cancer","volume":"25","author":"Barnholtz-Sloan","year":"2007","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2016.01.013_bib2","first-page":"89","article-title":"Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma","volume":"167","author":"Martins","year":"2002","journal-title":"J\u00a0Urol"},{"issue":"15S","key":"10.1016\/j.clgc.2016.01.013_bib3","doi-asserted-by":"crossref","first-page":"16029","DOI":"10.1200\/jco.2008.26.15_suppl.16029","article-title":"EGFR over-expression in squamous cell carcinoma of the penis","volume":"26","author":"Wood","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2016.01.013_bib4","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1200\/JCO.2006.07.2587","article-title":"Increased epidermal growth factor receptor copy number is associated with poor prognosis in head and neck squamous cell carcinomas","volume":"24","author":"Chung","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2016.01.013_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ygyno.2008.07.038","article-title":"Decreased survival in EGFR gene amplified vulvar carcinoma","volume":"111","author":"Growdon","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"15_suppl","key":"10.1016\/j.clgc.2016.01.013_bib6","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2010.28.15_suppl.e15022","article-title":"Epidermal growth factor receptor (EGFR) targeted therapy in advanced metastatic squamous cell carcinoma (AMSCC) of the penis: updates and molecular analyses","volume":"28","author":"Carthon","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2016.01.013_bib7","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S1470-2045(08)70206-7","article-title":"Assessment of somatic KRAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small cell lung cancer and metastatic colorectal cancer","volume":"9","author":"Linardou","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clgc.2016.01.013_bib8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.clgc.2013.09.006","article-title":"Clinicopathologic characteristics and outcomes of penile cancer treated at tertiary care centers in the western united states","volume":"12","author":"Jayaratna","year":"2014","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2016.01.013_bib9","doi-asserted-by":"crossref","first-page":"7861","DOI":"10.1158\/1078-0432.CCR-08-1056","article-title":"Her-2 gene amplification, Her-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer","volume":"14","author":"Press","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2016.01.013_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.clgc.2016.01.013_bib11","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ygyno.2005.09.029","article-title":"Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status","volume":"100","author":"Pappa","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clgc.2016.01.013_bib12","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1158\/1078-0432.CCR-09-1149","article-title":"Expression of epidermal growth factor receptor (EGFR) and activated EGFR predict poor response to (chemo)radiation and survival in cervical cancer","volume":"15","author":"Noordhuis","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2016.01.013_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ygyno.2010.10.034","article-title":"ERCC1 (excision repair cross-complementing group 1) expression as a predictor for response of neoadjuvant chemotherapy for FIGO stage 2B uterine cervix cancer","volume":"120","author":"Park","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clgc.2016.01.013_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000012000","article-title":"Enhanced expression of thymidylate synthase may be of prognostic importance in advanced cervical cancer","volume":"57","author":"Suzuki","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.clgc.2016.01.013_bib15","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/ijc.21454","article-title":"EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus","volume":"118","author":"Hanawa","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clgc.2016.01.013_bib16","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1158\/1078-0432.CCR-03-0079","article-title":"High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathologic response to neoadjuvant radiochemotherapy in esophageal cancer","volume":"10","author":"Warnecke-Eberz","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2016.01.013_bib17","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1158\/1078-0432.CCR-04-1387","article-title":"High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer","volume":"11","author":"Joshi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2016.01.013_bib18","first-page":"321","article-title":"Prevalence of RAS oncogene mutations in head and neck carcinomas","volume":"21","author":"Anderson","year":"1992","journal-title":"J\u00a0Otolaryngol"},{"key":"10.1016\/j.clgc.2016.01.013_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02893450","article-title":"Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas","volume":"12","author":"Hiraishi","year":"2006","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.clgc.2016.01.013_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.bjc.6604464","article-title":"ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation","volume":"99","author":"Jun","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clgc.2016.01.013_bib21","doi-asserted-by":"crossref","first-page":"8919","DOI":"10.1158\/0008-5472.CAN-04-2818","article-title":"Mutations of the epidermal growth factor receptor gene in lung cancer","volume":"64","author":"Kosaka","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.clgc.2016.01.013_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0169-5002(03)00225-3","article-title":"Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small cell lung cancer (NSCLC)","volume":"41","author":"Mukohara","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clgc.2016.01.013_bib23","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1158\/1078-0432.CCR-06-0106","article-title":"Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer","volume":"12","author":"Dziadziuszko","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2016.01.013_bib24","first-page":"2286","article-title":"Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer","volume":"8","author":"Lord","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2016.01.013_bib25","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/cncr.22208","article-title":"Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase","volume":"107","author":"Ceppi","year":"2006","journal-title":"Cancer"},{"issue":"suppl7","key":"10.1016\/j.clgc.2016.01.013_bib26","article-title":"BRAF and KRAS mutations in penile cancer and their correlation with clinical features","volume":"29","author":"Valverde","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2016.01.013_bib27","article-title":"Epidermal growth factor receptor (EGFR)-RAS signaling pathway in penile squamous cell carcinoma","volume":"8","author":"Goh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clgc.2016.01.013_bib28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3747\/co.v17i1.471","article-title":"EGFR overexpression in squamous cell carcinoma of the penis","volume":"17","author":"Lavens","year":"2010","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clgc.2016.01.013_bib29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1471-2164-9-246","article-title":"Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate","volume":"9","author":"Pascal","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/j.clgc.2016.01.013_bib30","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-ras mutations and benefit from cetuximab in advanced colorectal cancer","volume":"359","author":"Karapetis","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clgc.2016.01.013_bib31","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clgc.2016.01.013_bib32","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2016.01.013_bib33","first-page":"1407","article-title":"Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors","volume":"55","author":"Johnston","year":"1995","journal-title":"Cancer Res"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767316300131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767316300131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:25:00Z","timestamp":1761564300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767316300131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1558767316300131"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2016.01.013","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2016.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}